Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Naonobu, Futamura"'
Autor:
Kento Sakashita, Katsuya Nishida, Yu Takenaka, Ichiro Yokota, Hiroshi Yamasaki, Keisuke Nishimoto, Kunihiko Kawamoto, Maki Mitani, Itaru Funakawa, Nobuaki Yoshikura, Akio Kimura, Takayoshi Shimohata, Naonobu Futamura
Publikováno v:
Case Reports in Neurology, Vol 14, Iss 3, Pp 494-500 (2023)
Anti-metabotropic glutamate receptor 1 (mGluR1) encephalitis is a rare autoimmune disorder manifesting with cerebellar syndrome. Patients with mGluR1 encephalitis have been treated with immunomodulatory therapies; however, little is known about the e
Externí odkaz:
https://doaj.org/article/29041873b5c1419baea79794f9bacd6b
Autor:
Hiroaki Sekiya, Asato Tsuji, Yuki Hashimoto, Mariko Takata, Shunsuke Koga, Katsuya Nishida, Naonobu Futamura, Michi Kawamoto, Nobuo Kohara, Dennis W. Dickson, Hisatomo Kowa, Tatsushi Toda
Publikováno v:
Acta Neuropathologica Communications, Vol 10, Iss 1, Pp 1-13 (2022)
Abstract The pathological hallmarks of Parkinson’s disease (PD) are α-synuclein (αSYN)-positive inclusions referred to as Lewy bodies and Lewy neurites, collectively referred to as Lewy-related pathology (LRP). LRP is thought to propagate in an a
Externí odkaz:
https://doaj.org/article/4c4ffbf507a846fca4aa61e375060fe2
Autor:
Hiroyuki Todo, Katsuya Nishida, Ryuki Ando, Hiroshi Yamasaki, Naonobu Futamura, Itaru Funakawa
Publikováno v:
Annals of Indian Academy of Neurology, Vol 22, Iss 4, Pp 482-484 (2019)
Background: Although muscle ultrasound (MUS) is known to facilitate the diagnosis and evaluation of the severity of amyotrophic lateral sclerosis (ALS), the number of fasciculation has been scarcely examined as a predictive marker of the prognosis in
Externí odkaz:
https://doaj.org/article/da7311be712a49bda36d6e170ea3653c
Autor:
Katsuya Nishida, Naonobu Futamura
Publikováno v:
Stroke. 54
Publikováno v:
Parkinsonism & Related Disorders. 97:107-111
Tracheostomy invasive ventilation (TIV) is therapeutic intervention to prolong survival. However, few reports have addressed TIV in multiple system atrophy (MSA). This study sought to evaluate the impact of TIV on survival in MSA patients.This retros
Autor:
Tessa, Alessandra, Santorelli, Filippo Maria, Saffari, Afshin, Kellner, Melanie, Jordan, Catherine, Rosengarten, Helena, Mo, Alisa, Zhang, Bo, Strelko, Oleksandr, Neuser, Sonja, Davis, Marie Y, Yoshikura, Nobuaki, Naonobu Futamura, Takeuchi, Tomoya, Nabatame, Shin, Ishiura, Hiroyuki, Tsuji, Shoji, Assmann, Birgit, Yoon, Grace, Trombetta, Bianca A, Kivisäkk, Pia, Eichler, Florian, Haitian Nan, Takiyama, Yoshihisa, Sahin, Mustafa, Blackstone, Craig, Yang, Edward, Schüle, Rebecca, Ebrahimi-Fakhari, Darius
Research article "The clinical and molecular spectrum of ZFYVE26-associated hereditary spastic paraplegia: SPG15"
This study was supported by the Italian Ministry of Health (RF-2019-12370112)
This study was supported by the Italian Ministry of Health (RF-2019-12370112)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8156bb501d94e982c3f5a0a9c5afb907
Publikováno v:
Rinsho shinkeigaku = Clinical neurology. 62(4)
A 75-year-old man with a history of hypertension developed weakness and sensory disturbance in the extremities 1 week after upper respiratory tract infection and faced difficulty walking. Screening at the time of hospital admission revealed an incide
Autor:
Masakatsu Motomura, Naonobu Futamura, Hiroshi Yamasaki, Nobuo Kohara, Itaru Funakawa, Shunsuke Yoshimura
Publikováno v:
Internal medicine (Tokyo, Japan). 61(7)
We herein report two P/Q-type voltage-gated calcium channel (VGCC) antibody-positive Lambert-Eaton myasthenic syndrome (LEMS) patients who responded dramatically to cholinesterase inhibitors. Patient 1, a 76-year-old man, had small-cell lung cancer a
Autor:
Hiroaki Sekiya, Motoi Kanagawa, Wataru Satake, Motonori Takahashi, Itaru Funakawa, Kazuhiro Kobayashi, Tatsushi Toda, Hisatomo Kowa, Hinako Koga, Takeshi Kondo, Yasuhiro Ueno, Kenji Jinnai, Naonobu Futamura, Mariko Takata
Publikováno v:
Acta Neuropathologica. 137(3):455-466
Multiple system atrophy (MSA) is a fatal adult-onset neurodegenerative disease that is characterized by varying degrees of cerebellar dysfunction and Parkinsonism. The neuropathological hallmark of MSA is alpha-synuclein (AS)-positive glial cytoplasm
Autor:
Tsuyoshi Matsumura, Masashi Aoki, Kouzou Hanayama, Masanori P. Takahashi, T. Fukudome, H. Arahata, Naonobu Futamura, Harumasa Nakamura, Michio Kobayashi, Kiyonobu Komai, Hiroya Hashimoto, Yoshihide Sunada, Akinori Nakamura, Satoshi Kuru, Masatoshi Ishizaki, Yoshiki Adachi, Michinori Funato, Takashi Nakajima, Katsuhisa Ogata, Hiroto Takada, Tohru Matsuura, Shugo Suwazono
Publikováno v:
Neuromuscular Disorders
To clarify the influence of coronavirus disease-19 (COVID-19) on the care of muscular dystrophy patients, we performed a questionnaire survey that was posted on the internet on May 11, 2020. By the end of July 2020, 542 responses had been collected.